The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Oteseconazole Capsules were found to be safe and more effective than fluconazole
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
PEEK brings a new quality to dental care for patients
Subscribe To Our Newsletter & Stay Updated
